Bemiparin Terminated Phase 2 Trials for Carcinoma, Small Cell Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00324558Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY)